Voyager Therapeutics (VYGR) Tops Q2 EPS by 10c
Tweet
Share
E-mailGet Alerts VYGR Hot Sheet
Join SI Premium – FREE
Voyager Therapeutics (NASDAQ: VYGR) reported Q2 EPS of ($0.40), $0.10 better than the analyst estimate of ($0.50). Revenue for the quarter came in at $3.17 million versus the consensus estimate of $4.74 million.
For earnings history and earnings-related data on Voyager Therapeutics (VYGR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BTIG Reiterates Neutral Rating on MaxCyte Inc. (MXCT)
- Zeo Energy Corp (ZEO) files $150M mixed shelf
- XPeng robotics unit raises $900M at $6.3B valuation
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
